{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:14:34Z","timestamp":1791983674970,"version":"4.4.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Novartis Pharma AG"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To ascertain the perspectives of caregivers and patients with giant cell arteritis (GCA) and\/or polymyalgia rheumatica (PMR) and the impact of disease on quality of life (QOL) and identify their unmet needs through social media listening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study analysed social media posts from the USA and Germany between 1 August 2022 and 1 August 2023. A keyword search query retrieved posts addressing key research questions from various social media platforms using the Sprinklr tool. Natural language processing was used to assess the relevance of the posts, followed by a manual analysis to identify themes, map key topics and derive insights.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1001 unique posts, 517 were from patients or caregivers; these yielded 919 references to specific topics. Posts about PMR (65%) were more frequent than those about GCA (18%) or both (17%). The most common topics discussed by patients and caregivers were related to treatment (33%), symptoms (13%), healthcare professional (HCP) visits (10%), diagnosis (7%) and impact on QOL (7%). Among the mentions expressing treatment-related sentiment (n\u2009=\u2009297), negative sentiment was predominant (61%) across PMR- and GCA-related posts. Glucocorticoids were perceived more negatively than biologics. Patients reported significant impact of the disease on their QOL. Unmet needs were mostly related to experiences with HCPs and treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This novel social media listening study provides insights into the lived experiences of GCA and PMR. Patient conversations revealed multiple impacts on QOL and reflected a need for more effective, better-tolerated treatments and for greater disease awareness among healthcare professionals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rap\/rkaf140","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T13:12:32Z","timestamp":1764335552000},"source":"Crossref","is-referenced-by-count":1,"title":["Patient perspectives on life impact and unmet needs in giant cell arteritis and polymyalgia rheumatica: insights from social media"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-5873","authenticated-orcid":false,"given":"Sarah L","family":"Mackie","sequence":"first","affiliation":[{"name":"Leeds Institute for Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]},{"name":"NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Arun","sequence":"additional","affiliation":[{"name":"Novartis Healthcare Private Limited , Hyderabad,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"Novartis Healthcare Private Limited , Hyderabad,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Arjona","sequence":"additional","affiliation":[{"name":"Novartis Farmac\u00e9utica, S.A. , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce A","family":"Kullman","sequence":"additional","affiliation":[{"name":"Vasculitis Foundation , Kansas City, MO,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"2026010209364293300_rkaf140-B1","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(23)01310-7","article-title":"Polymyalgia rheumatica","volume":"402","author":"Esp\u00edgol-Frigol\u00e9","year":"2023","journal-title":"Lancet"},{"key":"2026010209364293300_rkaf140-B2","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1038\/s41433-024-03153-7","article-title":"The spectrum of giant cell arteritis through a rheumatology lens","volume":"38","author":"Khalique","year":"2024","journal-title":"Eye"},{"key":"2026010209364293300_rkaf140-B3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"2026010209364293300_rkaf140-B4","doi-asserted-by":"crossref","first-page":"103415","DOI":"10.1016\/j.autrev.2023.103415","article-title":"Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?","volume":"23","author":"Salvarani","year":"2024","journal-title":"Autoimmun Rev"},{"key":"2026010209364293300_rkaf140-B5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamainternmed.2020.3050","article-title":"Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis: a systematic review and meta-analysis","volume":"180","author":"van der Geest","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2026010209364293300_rkaf140-B6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard-2022-223429","article-title":"Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica","volume":"83","author":"Dejaco","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026010209364293300_rkaf140-B7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joim.13525","article-title":"An update on polymyalgia rheumatica","volume":"292","author":"Lundberg","year":"2022","journal-title":"J Intern Med"},{"key":"2026010209364293300_rkaf140-B8","doi-asserted-by":"crossref","first-page":"e0126758","DOI":"10.1371\/journal.pone.0126758","article-title":"\u201cAn impediment to living life\u201d: why and how should we measure stiffness in polymyalgia rheumatica?","volume":"10","author":"Mackie","year":"2015","journal-title":"PLoS One"},{"key":"2026010209364293300_rkaf140-B9","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","article-title":"Polymyalgia rheumatica","volume":"390","author":"Gonz\u00e1lez-Gay","year":"2017","journal-title":"Lancet"},{"key":"2026010209364293300_rkaf140-B10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jama.2024.7330","article-title":"What is polymyalgia rheumatica?","volume":"332","author":"Lall","year":"2024","journal-title":"JAMA"},{"key":"2026010209364293300_rkaf140-B11","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1093\/rheumatology\/keab076","article-title":"Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure","volume":"60","author":"Robson","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2026010209364293300_rkaf140-B12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/annrheumdis-2024-eular.2433","article-title":"POS1460-HPR Prevalence and management of patients with comorbidities and frailty in new onset polymyalgia rheumatica","volume":"83","author":"Sattui","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026010209364293300_rkaf140-B13","doi-asserted-by":"crossref","first-page":"rkad095","DOI":"10.1093\/rap\/rkad095","article-title":"Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank","volume":"7","author":"Chatzigeorgiou","year":"2023","journal-title":"Rheumatol Adv Pract"},{"key":"2026010209364293300_rkaf140-B14","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2026010209364293300_rkaf140-B15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"BSR and BHPR guidelines for the management of polymyalgia rheumatica","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2026010209364293300_rkaf140-B16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2026010209364293300_rkaf140-B17","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.semarthrit.2020.06.019","article-title":"The patient\u2019s perspective of the adverse effects of glucocorticoid use: a systematic review of quantitative and qualitative studies. From an OMERACT working group","volume":"50","author":"Cheah","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2026010209364293300_rkaf140-B18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40744-021-00290-3","article-title":"Treatment patterns, disease burden, and outcomes in patients with giant cell arteritis and polymyalgia rheumatica: a real-world, electronic health record-based study of patients in clinical practice","volume":"8","author":"Craig","year":"2021","journal-title":"Rheumatol Ther"},{"key":"2026010209364293300_rkaf140-B19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.rdc.2015.08.009","article-title":"Glucocorticoids for management of polymyalgia rheumatica and giant cell arteritis","volume":"42","author":"Matteson","year":"2016","journal-title":"Rheum Dis Clin"},{"key":"2026010209364293300_rkaf140-B20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.drudis.2022.01.015","article-title":"Applications of quantitative social media listening to patient-centric drug development","volume":"27","author":"Schmidt","year":"2022","journal-title":"Drug Discov Today"},{"key":"2026010209364293300_rkaf140-B21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s41666-021-00097-5","article-title":"Analyzing patient stories on social media using text analytics","volume":"5","author":"Zakkar","year":"2021","journal-title":"J Healthcare Inform Res"},{"key":"2026010209364293300_rkaf140-B22","volume-title":"Social media \u201clikes\u201d healthcare: from marketing to social business","author":"PricewaterhouseCoopers Health Research Institute","year":"2012"},{"key":"2026010209364293300_rkaf140-B23","doi-asserted-by":"crossref","first-page":"1274688","DOI":"10.3389\/fmed.2024.1274688","article-title":"Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators","volume":"11","author":"Cimiano","year":"2024","journal-title":"Front Med"},{"key":"2026010209364293300_rkaf140-B24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pec.2014.05.015","article-title":"Perceived healthcare provider reactions to patient and caregiver use of online health communities","volume":"96","author":"Rupert","year":"2014","journal-title":"Patient Educ Counsel"},{"key":"2026010209364293300_rkaf140-B25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12913-016-1691-0","article-title":"Social media use in healthcare: a systematic review of effects on patients and on their relationship with healthcare professionals","volume":"16","author":"Smailhodzic","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"2026010209364293300_rkaf140-B26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pec.2017.08.015","article-title":"How patients\u2019 use of social media impacts their interactions with healthcare professionals","volume":"101","author":"Benetoli","year":"2018","journal-title":"Patient Educ Counsel"},{"key":"2026010209364293300_rkaf140-B27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40744-023-00637-y","article-title":"Social listening in gout: impact of proactive vs. reactive management on self-reported emotional states","volume":"11","author":"Flurie","year":"2024","journal-title":"Rheumatol Ther"},{"key":"2026010209364293300_rkaf140-B28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s40744-023-00531-7","article-title":"Patient experience of Sj\u00f6gren\u2019s disease and its multifaceted impact on patients\u2019 lives","volume":"10","author":"Perella","year":"2023","journal-title":"Rheumatol Ther"},{"key":"2026010209364293300_rkaf140-B29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/acr.23600","article-title":"Patient concerns and perceptions regarding biologic therapies in ankylosing spondylitis: insights from a large-scale survey of social media platforms","volume":"71","author":"Dzubur","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2026010209364293300_rkaf140-B30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3899\/jrheum.170500","article-title":"Evaluation of self-reported patient experiences: insights from digital patient communities in psoriatic arthritis","volume":"45","author":"Sunkureddi","year":"2018","journal-title":"J Rheumatol"},{"key":"2026010209364293300_rkaf140-B31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/acr.24868","article-title":"Using patient-reported health data from social media to identify diverse lupus patients and assess their symptom and medication expressions: a feasibility study","volume":"75","author":"Venuturupalli","year":"2023","journal-title":"Arthritis Care Res"},{"key":"2026010209364293300_rkaf140-B32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pec.2014.12.013","article-title":"\u201cI suddenly felt I\u2019d aged\u201d: a qualitative study of patient experiences of polymyalgia rheumatica (PMR)","volume":"98","author":"Twohig","year":"2015","journal-title":"Patient Educ Counsel"},{"key":"2026010209364293300_rkaf140-B33","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00296-024-05634-0","article-title":"Social media has become a mainstream source of medical information for patients with rheumatic diseases: a cross-sectional survey of patients","volume":"44","author":"Myeoung","year":"2024","journal-title":"Rheumatol Int"},{"key":"2026010209364293300_rkaf140-B34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/acr.25216","article-title":"Treatment of polymyalgia rheumatica by rheumatology providers: analysis from the American College of Rheumatology RISE Registry","volume":"76","author":"Sattui","year":"2024","journal-title":"Arthritis Care Res"},{"key":"2026010209364293300_rkaf140-B35","doi-asserted-by":"crossref","first-page":"732934","DOI":"10.3389\/fmed.2021.732934","article-title":"Presentation and real-world management of giant cell arteritis (Artemis Study)","volume":"8","author":"Mahr","year":"2021","journal-title":"Front Med"},{"key":"2026010209364293300_rkaf140-B36","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/annrheumdis-2020-217333","article-title":"Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis","volume":"79","author":"Sharma","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2026010209364293300_rkaf140-B37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/RHU.0000000000000585","article-title":"A survey of glucocorticoid adverse effects and benefits in rheumatic diseases: the patient perspective","volume":"23","author":"Black","year":"2017","journal-title":"J Clin Rheumatol"},{"key":"2026010209364293300_rkaf140-B38","doi-asserted-by":"crossref","first-page":"105680","DOI":"10.1016\/j.jbspin.2023.105680","article-title":"Glucocorticoid treatment and clinical outcomes in patients with polymyalgia rheumatica: a cohort study using routinely collected health data","volume":"91","author":"Tanaka","year":"2024","journal-title":"Joint Bone Spine"},{"key":"2026010209364293300_rkaf140-B39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5114\/reum.2018.76900","article-title":"Diagnosis of polymyalgia rheumatica in primary health care: favoring and confounding factors \u2013 a cohort study","volume":"56","author":"Manzo","year":"2018","journal-title":"Reumatologia"},{"key":"2026010209364293300_rkaf140-B40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/a-2281-7092","article-title":"A survey of clinicians\u2019 views of the utility of large language models","volume":"15","author":"Spotnitz","year":"2024","journal-title":"Appl Clin Inform"},{"key":"2026010209364293300_rkaf140-B41","doi-asserted-by":"crossref","first-page":"e017073","DOI":"10.1136\/bmjopen-2017-017073","article-title":"What is the impact of giant cell arteritis on patients\u2019 lives? A UK qualitative study","volume":"7","author":"Liddle","year":"2017","journal-title":"BMJ Open"},{"key":"2026010209364293300_rkaf140-B42","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/art.11464","article-title":"Domains of health-related quality of life important to patients with giant cell arteritis","volume":"49","author":"Hellmann","year":"2003","journal-title":"Arthritis Care Res"},{"key":"2026010209364293300_rkaf140-B43","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/1744666X.2025.2521088","article-title":"Unmet needs in the management of giant cell arteritis and polymyalgia rheumatica","volume":"21","author":"Castaneda","year":"2025","journal-title":"Expert Rev Clin Immunol"},{"key":"2026010209364293300_rkaf140-B44","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/rheumatology\/kead643","article-title":"Estimating overdiagnosis in giant cell arteritis diagnostic pathways using genetic data: genetic association study","volume":"63","author":"Chatzigeorgiou","year":"2024","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkaf140\/65675356\/rkaf140.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/1\/rkaf140\/65675356\/rkaf140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/1\/rkaf140\/65675356\/rkaf140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T14:36:52Z","timestamp":1767364612000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkaf140\/8363211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkaf140","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2025,12,2]]},"article-number":"rkaf140"}}